About Zevra Therapeutics, Inc. 
Zevra Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 31 Schemes (19.34%)
Foreign Institutions
Held by 31 Foreign Institutions (3.72%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Jun 2025)
Net Profit:
75 Million
Pharmaceuticals & Biotechnology
USD 468 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.21
53.63%
3.99






